SFRS14 antibody
Principal name
SFRS14 antibody
Alternative names for SFRS14 antibody
KIAA0365, Putative splicing factor arginine/serine-rich 14, Arginine/serine-rich-splicing factor 14
Ncbi ID
9606, NP_001017392.2, NM_001017392, NP_001161762.1, NM_001168290, NM_014884
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Immunocytochemistry/Immunofluorescence (ICC/IF), Western blot / Immunoblot (WB), Paraffin Sections (P), ELISA (detection) (E(detection)), Immunoprecipitation (IP)
Background of SFRS14 antibody
- Kit Component:
- - KN316956G1, Sfrs14 gRNA vector 1 in pCas-Guide vector
- KN316956G2, Sfrs14 gRNA vector 2 in pCas-Guide vector
- KN316956D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Immunoperoxidase of monoclonal antibody to SFRS14 on formalin-fixed paraffin-embedded human testis. [antibody concentration 3 ug/ml]
Immunofluorescence of monoclonal antibody to SFRS14 on HeLa cell. [antibody concentration 10 ug/ml]
SFRS14 monoclonal antibody (M01), clone 3C5 Western Blot analysis of SFRS14 expression in Hela NE ( Cat # L013V3 ).
Western Blot analysis of SFRS14 expression in transfected 293T cell line (H00010147-T01) by SFRS14 MaxPab polyclonal antibody.Lane 1: SFRS14 transfected lysate(108.68 KDa).Lane 2: Non-transfected lysate.
Western Blot analysis of SFRS14 expression in transfected 293T cell line (H00010147-T02) by SFRS14 MaxPab polyclonal antibody.Lane 1: SFRS14 transfected lysate(110.40 KDa).Lane 2: Non-transfected lysate.
Lysates
| Catalog No. | ||
|---|---|---|
| LY422773 | SUGP2 overexpression lysate |
|
 |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. |
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC211778L2V | Lenti ORF particles, SUGP2 (mGFP-tagged) - Human SURP and G patch domain containing 2 (SUGP2), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,300.00
|
|
| OriGene Technologies, Inc. | ||
| RC219335L2V | Lenti ORF particles, SUGP2 (mGFP-tagged)-Human SURP and G patch domain containing 2 (SUGP2), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,300.00
|
|
| OriGene Technologies, Inc. | ||
| RC211778L1V | Lenti ORF particles, SUGP2 (Myc-DDK tagged) - Human SURP and G patch domain containing 2 (SUGP2), transcript variant 1 , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,080.00
|
|
| OriGene Technologies, Inc. | ||
| RC219335L1V | Lenti ORF particles, SUGP2 (Myc-DDK-tagged)-Human SURP and G patch domain containing 2 (SUGP2), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,080.00
|
|
| OriGene Technologies, Inc. | ||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR210140L2V | Lenti ORF particles, Sugp2 (GFP-tagged) - Mouse SURP and G patch domain containing 2 (Sugp2), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,470.00
|
|
| OriGene Technologies, Inc. | ||
| MR210140L1V | Lenti ORF particles, Sugp2 (Myc-DDK-tagged) - Mouse SURP and G patch domain containing 2 (Sugp2), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,330.00
|
|
| OriGene Technologies, Inc. | ||